Bioprocess Bags Global Market Report 2024

The bioprocess bags market size has grown rapidly in recent years. It will grow from $2.76 billion in 2023 to $3.25 billion in 2024 at a compound annual growth rate (CAGR) of 17.9%. The observed growth during the historical period can be attributed to factors such as increased adoption of single-use bioreactors, a heightened focus on contamination prevention, cost savings in bioprocessing operations, the rise of the biopharmaceutical industry, and enhanced flexibility in bioproduction processes.

The bioprocess bags market size is expected to see rapid growth in the next few years. It will grow to $5.92 billion in 2028 at a compound annual growth rate (CAGR) of 16.2%. The anticipated growth in the forecast period can be attributed to factors such as improved sterilization techniques, enhanced quality control measures, the adoption of next-generation bioprocessing solutions, a shift towards modular bioprocessing, a rising demand for personalized medicines, an increased demand for biologics, and bioprocess bags with enhanced connectivity. Major trends expected in the forecast period include advances in biopharmaceutical manufacturing, progress in single-use technologies, the development of high-capacity bioprocess bags, the use of sustainable and eco-friendly bioprocess materials, and the integration of artificial intelligence in bioprocessing.

The anticipated rapid expansion of biotechnology firms is set to be a driving force behind the growth of the bioprocess bag market. Biotechnology companies leverage biological knowledge, tools, and techniques to create products and services across various industries. Bioprocess bags offer numerous advantages to the biotechnology sector, including reduced environmental impact, flexibility, cost-effectiveness, time efficiency, and contamination control. According to the World Bank's February 2022 report, small biotechnology firms contributed to 70% of new drug approvals in the US, achieving a 9.3% return on research and development investment compared to 1.9% for pharmaceutical companies. Moreover, in January 2022, the BioIndustry Association reported that investments in the UK biotech and life sciences industries reached a record high in 2021, totaling $6.06 billion (£4.5 billion), a 60% increase from 2020. Hence, the rapid growth of biotechnology firms is a significant driver for the bioprocess bag market.

The escalating prevalence of chronic diseases is poised to fuel the growth of the bioprocess bag market. Chronic diseases, lasting three months or more and worsening over time, necessitate bioprocess bags in the production of biopharmaceuticals. These bags serve as integral components in single-use biomanufacturing systems, enabling the sterile containment and processing of cell cultures, growth media, and therapeutic proteins. This approach ensures a flexible, cost-effective, and contamination-resistant manufacturing process for complex biologics tailored to treat chronic diseases. According to the National Center for Biotechnology Information (NCBI) in January 2023, the global number of people with chronic diseases is projected to reach 142.66 million by 2050, doubling from 71.522 million in 2020. Consequently, the growing prevalence of chronic diseases is a key driver for the bioprocess bag market.

The adoption of single-use technologies stands out as a prominent trend in the bioprocess bag market, with major companies focusing on the development of single-use bags to maintain their market positions. In October 2022, Single Use Support GmbH, an Austria-based manufacturer of single-use technologies, introduced the IRIS single-use bioprocessing bag line. This customizable product line caters to customer-specific volume, port, and tubing requirements, suitable for cryopreservation and capable of sustaining temperatures as low as -150 °C.

Major companies in the bioprocess bag market are introducing innovative products such as single-use process container films to gain a competitive advantage. Single-use process container films, designed for constructing single-use process containers in bioprocessing and pharmaceutical manufacturing, are a focus for these companies. In April 2023, Merck KGaA, a Germany-based pharmaceutical company, launched the Ultimus Single-Use Process Container Film. Engineered with a proprietary woven nylon structure, this film offers extreme durability, leak resistance, and significant improvements in strength and puncture resistance compared to other single-use bioprocessing films. This advancement aims to minimize disruptions in manufacturing operations and enhance overall operational efficiency, meeting regulatory requirements with an animal origin-free contact resin.

In June 2021, Avantor Inc., a US-based company specializing in instruments, chemicals, and lab supplies, acquired RIM Bio for an undisclosed amount. This acquisition strengthened Avantor's capabilities in the production, distribution, and cleanrooms for single-use products, as RIM Bio is a China-based manufacturer of bioprocess bags and assemblies.

Major companies operating in the bioprocess bags market report are Saint-Gobain Group, Charter Medical LLC, Thermo Fisher Scientific Inc., 3M Company, Danaher Corporation, Merck KGaA, GE Healthcare, Parker Hannifin Corporation, Corning Incorporated, Avantor Inc., Lonza Group, GEA Group Aktiengesellschaft, Sartorius AG, Cellon SA, Entegris Inc., W. L. Gore & Associates Inc., West Pharmaceutical Services Inc., Eppendorf AG, Repligen Corporation, Cole-Parmer Instrument Company LLC., ESI Technologies Group, Colder Products Company, CellBios Healthcare and Lifesciences Pvt Ltd., PBS Biotech, Flexicon Liquid Filling Systems, Meissner Filtration Products Inc., MilliporeSigma.

North America was the largest region in the bioprocess bags market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess bags market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioprocess bags market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The main types of bioprocess bags include 2D bioprocess bags, 3D bioprocess bags, and others. 2D bioprocess bags are flexible containers or bags with a flat, two-dimensional shape when empty or before filling. These bags cater to various workflows, including upstream processes, downstream processes, and process development, with capacities ranging from small to extra-large. They find applications in buffer and media storage, cell culture, cell separation and harvest, chromatography feed and collection, ultrafiltration and diafiltration, intermediate and final product hold, and others. Additionally, bioprocess bags are utilized by various end-users, including pharmaceutical companies, biopharmaceutical companies, biotechnology labs, and academic labs.

The bioprocess bags market research report is one of a series of new reports that provides bioprocess bags market statistics, including the bioprocess bags industry's global market size, regional shares, competitors with a bioprocess bags market share, detailed bioprocess bags market segments, market trends, and opportunities, and any further data you may need to thrive in the bioprocess bags industry. This bioprocess bags market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bioprocess bags market consists of sales of wave rocker bags, single-use mixing systems, and filter bag systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.